Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | ANIP | NRIX | ||
| Company | Recursion Pharmaceuticals Inc Cl A | ANI Pharma Inc | Nurix Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.09 | 73.95 | 15.35 | ||
| High | 3.12 | 74.65 | 15.55 | ||
| Low | 2.91 | 72.60 | 14.75 | ||
| Latest | 2.94 | 72.82 | 14.76 | ||
| Change | -0.21 | -1.32 | -0.77 | ||
| % Change | -6.67% | -1.78% | -4.96% | ||
| Volume | 19,287,301 | 130,700 | 1,177,800 | ||
| 20-Day Average Volume | 13,979,755 | 382,425 | 1,236,245 | ||
| Previous Close | 3.15 | 74.14 | 15.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.37 | 74.29 | 15.32 | ||
| 20-Day Raw Stochastic | 3.53% | 34.14% | 30.67% | ||
| 20-Day Relative Strength | 33.14 | 42.32 | 43.28 | ||
| Weighted Alpha | -56.44 | -4.87 | +14.67 | ||
| Today's Opinion | 100% Sell | 100% Sell | 8% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 8% Buy | ||
| Last Month's Opinion | 96% Sell | 72% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.54% since 03/20/26 | -2.48% since 03/20/26 | +2.29% since 03/20/26 | ||
| Low | 2.91 on 03/27/26 | 72.60 on 03/27/26 | 14.01 on 03/24/26 | ||
| High | 3.33 on 03/23/26 | 75.95 on 03/23/26 | 16.20 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -19.89% since 02/27/26 | -1.46% since 02/27/26 | -7.58% since 02/27/26 | ||
| Low | 2.91 on 03/27/26 | 70.15 on 03/13/26 | 14.01 on 03/24/26 | ||
| High | 3.76 on 03/04/26 | 77.97 on 03/03/26 | 16.45 on 03/04/26 | ||
| 3-Month | |||||
| %Chg | -30.82% since 12/26/25 | -11.64% since 12/26/25 | -23.52% since 12/26/25 | ||
| Low | 2.91 on 03/27/26 | 70.15 on 03/13/26 | 14.01 on 03/24/26 | ||
| High | 5.24 on 01/22/26 | 87.07 on 01/16/26 | 20.18 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | -37.71% since 09/26/25 | -21.74% since 09/26/25 | +65.29% since 09/26/25 | ||
| Low | 2.91 on 03/27/26 | 70.15 on 03/13/26 | 8.85 on 10/02/25 | ||
| High | 7.18 on 10/20/25 | 97.00 on 10/24/25 | 22.50 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,661,304 | 1,661,773 | 1,597,152 | ||
| Shares Outstanding, K | 527,398 | 22,414 | 102,843 | ||
| Annual Sales | 74,680,000 | 883,370,000 | 83,980,000 | ||
| Annual Net Income | -644,760,000 | 78,340,000 | -264,460,000 | ||
| Last Quarter Sales | 35,540,000 | 247,060,000 | 13,580,000 | ||
| Last Quarter Net Income | -108,120,000 | 27,490,000 | -78,220,000 | ||
| 60-Month Beta | 0.97 | 0.52 | 1.96 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 02/25/26 | 2.33 on 02/27/26 | -0.82 on 01/28/26 | ||
| Latest Earnings Date | 05/04/26 | 05/08/26 | 04/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.63 | 0.00 | ||